MedTrace Logo

Combined Effect of CIMT and Brunnstrom Therapy on UE in Stroke Patients

NCT06762249 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-01-07

No results posted yet for this study

Summary

Stroke is a leading cause of disability characterized by inadequate blood supply to the brain, leading to cell death and neurological deficits. Motor impairment of the upper extremity is a common consequence among stroke patients, resulting in paralysis of the upper limb. Both Constraint Induced Movement Therapy and Brunnstrom therapy have shown promise in improving motor activity and overall quality of life in stroke patients.This randomized controlled trial will be carried out at in Multan over 10 months. Total number of 56 participants meeting the inclusion criteria will be included in this study. Participants will be randomly assigned into 2 groups . Both groups will receive interventions for five days a week for 4 weeks.

Conditions

  • Stroke Patients

Interventions

OTHER

CIMT + Brunnstrom therapy + routine physical therapy

this therapy will be given for 5 days per week for 4 weeks.

OTHER

CIMT + routine physical therapy

this therapy will be given for 5 days per week for 4 weeks

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Sabiha Arshad · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-02-01
Completion
2025-05-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06762249 on ClinicalTrials.gov